Segment disclosures

Company overview

인바이츠바이오코아

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 4 retained observations 4 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3116643930380 KRW20260612Open filing evidence
2024-01-01 – 2024-12-3112907443606 RestatedKRW20260612Open filing evidence
2023-01-01 – 2023-12-3113307139447 RestatedKRW20260612Open filing evidence
2022-01-01 – 2022-12-3125356985229 KRW20250318Open filing evidence